245 related articles for article (PubMed ID: 24588905)
1. Efficacy of zoledronic acid for chronic low back pain associated with Modic changes in magnetic resonance imaging.
Koivisto K; Kyllönen E; Haapea M; Niinimäki J; Sundqvist K; Pehkonen T; Seitsalo S; Tervonen O; Karppinen J
BMC Musculoskelet Disord; 2014 Mar; 15():64. PubMed ID: 24588905
[TBL] [Abstract][Full Text] [Related]
2. The effect of zoledronic acid on type and volume of Modic changes among patients with low back pain.
Koivisto K; Järvinen J; Karppinen J; Haapea M; Paananen M; Kyllönen E; Tervonen O; Niinimäki J
BMC Musculoskelet Disord; 2017 Jun; 18(1):274. PubMed ID: 28645291
[TBL] [Abstract][Full Text] [Related]
3. Oral Zoledronic acid bisphosphonate for the treatment of chronic low back pain with associated Modic changes: A pilot randomized controlled trial.
Shea GKH; Zhang C; Suen WS; Cheung PWH; Cheung JPY; Maatta J; Karppinen J; Samartzis D
J Orthop Res; 2022 Dec; 40(12):2924-2936. PubMed ID: 35195306
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic treatment In patients with chronic low back pain and Modic changes (the AIM study): study protocol for a randomised controlled trial.
Storheim K; Espeland A; Grøvle L; Skouen JS; Aßmus J; Anke A; Froholdt A; Pedersen LM; Haugen AJ; Fors T; Schistad E; Lutro O; Marchand GH; Kadar T; Vetti N; Randen S; Nygaard ØP; Brox JI; Grotle M; Zwart JA
Trials; 2017 Dec; 18(1):596. PubMed ID: 29246188
[TBL] [Abstract][Full Text] [Related]
5. Effect of Zoledronic Acid and Denosumab in Patients With Low Back Pain and Modic Change: A Proof-of-Principle Trial.
Cai G; Laslett LL; Aitken D; Halliday A; Pan F; Otahal P; Speden D; Winzenberg TM; Jones G
J Bone Miner Res; 2018 May; 33(5):773-782. PubMed ID: 29297602
[TBL] [Abstract][Full Text] [Related]
6. Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial.
Laslett LL; Doré DA; Quinn SJ; Boon P; Ryan E; Winzenberg TM; Jones G
Ann Rheum Dis; 2012 Aug; 71(8):1322-8. PubMed ID: 22355040
[TBL] [Abstract][Full Text] [Related]
7. Association between changes in lumbar Modic changes and low back symptoms over a two-year period.
Järvinen J; Karppinen J; Niinimäki J; Haapea M; Grönblad M; Luoma K; Rinne E
BMC Musculoskelet Disord; 2015 Apr; 16():98. PubMed ID: 25897658
[TBL] [Abstract][Full Text] [Related]
8. Association of Modic change types and their short tau inversion recovery signals with clinical characteristics- a cross sectional study of chronic low back pain patients in the AIM-study.
Bråten LCH; Schistad EI; Espeland A; Kristoffersen PM; Haugen AJ; Marchand GH; Vetti N; Pripp AH; Kadar TI; Skouen JS; Grotle M; Grøvle L; Zwart JA; Brox JI; Storheim K;
BMC Musculoskelet Disord; 2020 Jun; 21(1):368. PubMed ID: 32522268
[TBL] [Abstract][Full Text] [Related]
9. TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer.
James N; Pirrie S; Pope A; Barton D; Andronis L; Goranitis I; Collins S; McLaren D; O'Sullivan J; Parker C; Porfiri E; Staffurth J; Stanley A; Wylie J; Beesley S; Birtle A; Brown J; Chakraborti P; Russell M; Billingham L
Health Technol Assess; 2016 Jul; 20(53):1-288. PubMed ID: 27434595
[TBL] [Abstract][Full Text] [Related]
10. Effect of Intravenous Zoledronic Acid on Tibiofemoral Cartilage Volume Among Patients With Knee Osteoarthritis With Bone Marrow Lesions: A Randomized Clinical Trial.
Cai G; Aitken D; Laslett LL; Pelletier JP; Martel-Pelletier J; Hill C; March L; Wluka AE; Wang Y; Antony B; Blizzard L; Winzenberg T; Cicuttini F; Jones G
JAMA; 2020 Apr; 323(15):1456-1466. PubMed ID: 32315057
[TBL] [Abstract][Full Text] [Related]
11. Effect of zoledronic acid on lumbar spinal fusion in osteoporotic patients.
Ding Q; Chen J; Fan J; Li Q; Yin G; Yu L
Eur Spine J; 2017 Nov; 26(11):2969-2977. PubMed ID: 28865035
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of antibiotic treatment in patients with chronic low back pain and Modic changes (the AIM study): double blind, randomised, placebo controlled, multicentre trial.
Bråten LCH; Rolfsen MP; Espeland A; Wigemyr M; Aßmus J; Froholdt A; Haugen AJ; Marchand GH; Kristoffersen PM; Lutro O; Randen S; Wilhelmsen M; Winsvold BS; Kadar TI; Holmgard TE; Vigeland MD; Vetti N; Nygaard ØP; Lie BA; Hellum C; Anke A; Grotle M; Schistad EI; Skouen JS; Grøvle L; Brox JI; Zwart JA; Storheim K;
BMJ; 2019 Oct; 367():l5654. PubMed ID: 31619437
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic treatment in patients with chronic low back pain and vertebral bone edema (Modic type 1 changes): a double-blind randomized clinical controlled trial of efficacy.
Albert HB; Sorensen JS; Christensen BS; Manniche C
Eur Spine J; 2013 Apr; 22(4):697-707. PubMed ID: 23404353
[TBL] [Abstract][Full Text] [Related]
14. Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial.
Wilkens P; Scheel IB; Grundnes O; Hellum C; Storheim K
JAMA; 2010 Jul; 304(1):45-52. PubMed ID: 20606148
[TBL] [Abstract][Full Text] [Related]
15. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.
Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL
Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638
[TBL] [Abstract][Full Text] [Related]
16. Refined Phenotyping of Modic Changes: Imaging Biomarkers of Prolonged Severe Low Back Pain and Disability.
Määttä JH; Karppinen J; Paananen M; Bow C; Luk KDK; Cheung KMC; Samartzis D
Medicine (Baltimore); 2016 May; 95(22):e3495. PubMed ID: 27258491
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous vertebroplasty combined with zoledronic acid for the treatment of painful osteolytic spinal metastases in patients with breast cancer.
Zhang J; Wang Y; Han K; Tang L; Hu H; Wu C; Shen Z; Sun Y; Yao Y
J Vasc Interv Radiol; 2013 Dec; 24(12):1861-7. PubMed ID: 24144536
[TBL] [Abstract][Full Text] [Related]
18. Modic Changes Are Not Associated With Long-term Pain and Disability: A Cohort Study With 13-year Follow-up.
Udby PM; Bendix T; Ohrt-Nissen S; Lassen MR; Sørensen JS; Brorson S; Carreon LY; Andersen MØ
Spine (Phila Pa 1976); 2019 Sep; 44(17):1186-1192. PubMed ID: 30985571
[TBL] [Abstract][Full Text] [Related]
19. Type 1 Modic changes was a significant risk factor for 1-year outcome in sick-listed low back pain patients: a nested cohort study using magnetic resonance imaging of the lumbar spine.
Jensen OK; Nielsen CV; Sørensen JS; Stengaard-Pedersen K
Spine J; 2014 Nov; 14(11):2568-81. PubMed ID: 24534386
[TBL] [Abstract][Full Text] [Related]
20. Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors.
Henry D; Vadhan-Raj S; Hirsh V; von Moos R; Hungria V; Costa L; Woll PJ; Scagliotti G; Smith G; Feng A; Jun S; Dansey R; Yeh H
Support Care Cancer; 2014 Mar; 22(3):679-87. PubMed ID: 24162260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
